Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Apr 19 '24 | Sale | 65.17 | 16,809 | 1,095,443 | 782,620 | Apr 22 06:26 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Apr 18 '24 | Sale | 64.98 | 10,423 | 677,287 | 799,429 | Apr 22 06:26 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Apr 17 '24 | Sale | 65.40 | 9,520 | 622,608 | 809,852 | Apr 17 04:33 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Apr 16 '24 | Sale | 66.20 | 5,834 | 386,211 | 819,372 | Apr 17 04:33 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Apr 15 '24 | Sale | 66.33 | 7,414 | 491,771 | 825,206 | Apr 17 04:33 PM | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Apr 12 '24 | Sale | 67.79 | 250 | 16,948 | 59,731 | Apr 15 06:28 PM | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Apr 01 '24 | Sale | 67.25 | 20,000 | 1,345,000 | 253,226 | Apr 02 06:59 PM | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Mar 13 '24 | Sale | 66.54 | 250 | 16,635 | 59,981 | Mar 13 04:48 PM | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Mar 11 '24 | Sale | 65.81 | 20,000 | 1,316,200 | 273,226 | Mar 13 04:44 PM | CAREY STEPHEN P. | SVP & CFO | Mar 11 '24 | Sale | 65.55 | 7,787 | 510,438 | 177,712 | Mar 11 06:39 PM | Lalwani Nikhil | PRESIDENT & CEO | Mar 08 '24 | Sale | 67.13 | 16,292 | 1,093,682 | 411,629 | Mar 08 07:25 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 08 '24 | Sale | 67.17 | 10,000 | 671,700 | 832,620 | Mar 11 06:43 PM | Marken James G. | SVP OPS & PROD DEV | Mar 07 '24 | Sale | 66.37 | 24,338 | 1,615,313 | 124,492 | Mar 07 09:42 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 07 '24 | Sale | 66.35 | 15,085 | 1,000,890 | 842,620 | Mar 07 09:11 PM | Lalwani Nikhil | PRESIDENT & CEO | Mar 06 '24 | Sale | 65.52 | 28,965 | 1,897,787 | 444,981 | Mar 08 07:25 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 06 '24 | Sale | 65.47 | 14,822 | 970,396 | 857,705 | Mar 07 09:11 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 05 '24 | Sale | 65.35 | 10,093 | 659,578 | 872,527 | Mar 07 09:11 PM | Mutz Christopher | HEAD OF RARE DISEASE | Mar 05 '24 | Sale | 66.00 | 5,000 | 330,000 | 87,387 | Mar 06 04:24 PM | Pera Antonio R | Director | Mar 04 '24 | Sale | 65.20 | 7,000 | 456,400 | 26,627 | Mar 06 04:20 PM | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Feb 13 '24 | Sale | 56.04 | 250 | 14,010 | 36,799 | Feb 13 08:05 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 23 '24 | Sale | 56.44 | 15,000 | 846,600 | 882,620 | Jan 23 05:32 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 22 '24 | Sale | 55.95 | 5,692 | 318,467 | 897,620 | Jan 23 05:32 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 19 '24 | Sale | 55.57 | 4,524 | 251,399 | 903,312 | Jan 23 05:32 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 18 '24 | Sale | 55.30 | 9,784 | 541,055 | 907,836 | Jan 18 06:20 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 17 '24 | Sale | 55.11 | 10,000 | 551,100 | 917,620 | Jan 18 06:20 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 16 '24 | Sale | 55.63 | 5,000 | 278,150 | 927,620 | Jan 18 06:20 PM | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Jan 12 '24 | Sale | 56.43 | 250 | 14,108 | 37,049 | Jan 16 09:09 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Dec 19 '23 | Sale | 52.65 | 25,000 | 1,316,250 | 932,620 | Dec 19 05:44 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Dec 18 '23 | Sale | 52.44 | 13,026 | 683,083 | 957,620 | Dec 19 05:44 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Dec 15 '23 | Sale | 52.44 | 11,974 | 627,917 | 970,646 | Dec 19 05:44 PM | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Dec 11 '23 | Sale | 49.21 | 250 | 12,302 | 37,299 | Dec 11 05:49 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 17 '23 | Sale | 51.00 | 13,000 | 663,000 | 982,620 | Nov 20 09:05 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 16 '23 | Sale | 51.66 | 6,448 | 333,104 | 996,430 | Nov 16 06:11 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 15 '23 | Sale | 53.64 | 7,647 | 410,185 | 1,002,878 | Nov 16 06:11 PM | Davis Krista | SVP, CHIEF HR OFFICER | Nov 15 '23 | Sale | 53.81 | 2,622 | 141,090 | 32,587 | Nov 16 06:13 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 14 '23 | Sale | 53.17 | 22,095 | 1,174,791 | 1,010,525 | Nov 16 06:11 PM | Mutz Christopher | HEAD OF RARE DISEASE | Nov 10 '23 | Sale | 52.47 | 3,000 | 157,410 | 63,607 | Nov 13 04:02 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 19 '23 | Sale | 57.06 | 10,000 | 570,600 | 1,032,620 | Oct 19 04:28 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 18 '23 | Sale | 57.78 | 6,242 | 360,663 | 1,042,620 | Oct 19 04:28 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 17 '23 | Sale | 58.53 | 8,758 | 512,606 | 1,048,862 | Oct 19 04:28 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 16 '23 | Sale | 58.31 | 13,063 | 761,704 | 1,057,620 | Oct 17 04:32 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 13 '23 | Sale | 57.58 | 11,937 | 687,332 | 1,070,683 | Oct 17 04:32 PM | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Oct 02 '23 | Sale | 56.48 | 20,000 | 1,129,600 | 293,226 | Oct 03 08:00 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Sep 19 '23 | Sale | 61.23 | 25,333 | 1,551,140 | 1,082,620 | Sep 19 05:14 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Sep 18 '23 | Sale | 61.64 | 8,425 | 519,317 | 1,107,953 | Sep 19 05:14 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Sep 15 '23 | Sale | 62.81 | 16,242 | 1,020,160 | 1,116,378 | Sep 19 05:14 PM | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Sep 01 '23 | Sale | 64.70 | 20,000 | 1,294,000 | 313,226 | Sep 05 05:06 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 29 '23 | Sale | 63.37 | 25,000 | 1,584,250 | 1,132,620 | Aug 30 04:29 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 28 '23 | Sale | 63.06 | 25,000 | 1,576,500 | 1,157,620 | Aug 30 04:29 PM | Gutwerg Ori | SVP, GENERICS | Aug 23 '23 | Option Exercise | 31.49 | 13,502 | 425,178 | 76,476 | Aug 25 04:22 PM | Marken James G. | SVP OPS & PROD DEV | Aug 23 '23 | Option Exercise | 38.25 | 5,417 | 207,224 | 137,044 | Aug 25 04:17 PM | Gutwerg Ori | SVP, GENERICS | Aug 23 '23 | Sale | 62.39 | 15,561 | 970,851 | 60,915 | Aug 25 04:22 PM | Marken James G. | SVP OPS & PROD DEV | Aug 23 '23 | Sale | 63.00 | 3,932 | 247,716 | 133,112 | Aug 25 04:17 PM | MERIDIAN VENTURE PARTNERS II L | 10% Owner | Aug 16 '23 | Sale | 58.50 | 200,000 | 11,700,000 | 1,819,259 | Aug 16 08:00 PM | Lalwani Nikhil | PRESIDENT & CEO | Aug 15 '23 | Option Exercise | 29.00 | 11,616 | 336,864 | 365,006 | Aug 15 08:39 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 15 '23 | Sale | 61.60 | 22,110 | 1,361,976 | 1,182,620 | Aug 16 07:07 PM | Lalwani Nikhil | PRESIDENT & CEO | Aug 15 '23 | Sale | 61.13 | 11,616 | 710,086 | 353,390 | Aug 15 08:39 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 14 '23 | Sale | 61.15 | 27,890 | 1,705,474 | 1,204,730 | Aug 16 07:07 PM | CAREY STEPHEN P. | SVP & CFO | Aug 14 '23 | Sale | 61.37 | 17,639 | 1,082,505 | 155,839 | Aug 16 04:24 PM | Pera Antonio R | Director | Aug 14 '23 | Sale | 60.37 | 3,000 | 181,110 | 33,627 | Aug 15 08:45 PM | Lalwani Nikhil | PRESIDENT & CEO | Aug 11 '23 | Sale | 57.75 | 56,666 | 3,272,462 | 353,390 | Aug 15 08:39 PM | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Aug 01 '23 | Sale | 51.06 | 20,000 | 1,021,200 | 333,226 | Aug 03 06:03 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 21 '23 | Sale | 52.56 | 11,500 | 604,440 | 1,232,620 | Jul 21 07:15 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 20 '23 | Sale | 51.52 | 6,000 | 309,120 | 1,244,120 | Jul 21 07:15 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 19 '23 | Sale | 51.48 | 5,969 | 307,284 | 1,250,120 | Jul 21 07:15 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 18 '23 | Sale | 51.84 | 6,700 | 347,328 | 1,256,089 | Jul 18 08:06 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 17 '23 | Sale | 51.06 | 9,831 | 501,971 | 1,262,789 | Jul 18 08:06 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 14 '23 | Sale | 50.43 | 10,000 | 504,300 | 1,272,620 | Jul 18 08:06 PM | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Jul 03 '23 | Sale | 53.43 | 20,000 | 1,068,600 | 353,226 | Jul 06 04:15 PM | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Jun 22 '23 | Sale | 51.32 | 20,000 | 1,026,400 | 373,226 | Jun 23 08:00 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 22 '23 | Sale | 51.38 | 13,500 | 693,630 | 7,407 | Jun 22 08:00 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 21 '23 | Sale | 51.95 | 11,843 | 615,244 | 20,907 | Jun 22 08:00 PM | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 20 '23 | Sale | 51.93 | 14,657 | 761,138 | 32,750 | Jun 22 08:00 PM |
|